6. Crea F., Liuzzo G. Pathogenesis of acute coronary syndromes // Journal of the American College of Cardiology. 2013. Vol. 61. № 1. P. 1-11.
7. Ikitimur B, Karadag B. Role of myeloperoxidase in cardiology // Future Cardiol. 2010. Vol. 6. P. 693-702.
8. Lau D., Baldus S. Myeloperoxidase and its contributory role in inflammatory vascular disease // Pharmacol. Therapeut. 2006. Vol. 111. P. 16-26.
9. Niccoli G., Montone R.A., Cataneo L. et al. Morphological-biohumoral correlations in acute coronary syndromes: pathogenetic implications // Int J Cardiol. 2014; 171:463-466.
10. Nicholls S.J., Hazen S.l. Myeloperoxidase and cardiovascular disease // Arterioscl. Throm. Vas. Biol. 2005. Vol. 25. P. 1102-1111.
11. Perk J. The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) // European Heart Journal. 2012. № 33. P. 1635-1700.
12. Rader D.J. Inflammatory markers of coronary risk // N. Eng. J. Med. - 2000. - Vol. 343. - P. 1179-1182.
13. Ridker P.M., Hennekens C.H., Buring J.E. et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. - N. Engl. J. Med. - 2000. - Vol. 342. - P. 836-843.
14. Ross R. Atherosclerosis as an inflammatory disease // New Engl J Med. 1999. Vol. 340. P. 115-26.
15. Sugiyama S., Okada Y., Sukhova G.K., Virmani R., Heinecke J.W., Libby P. Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes // Am J ClinPathol. 2001. Vol. 158. P. 879-891.
16. Van de Werf F. and Crea C. The year in cardiology 2014: acute coronary Syndromes // European Heart Journal Advance Access January 2, 2015. P. 1-6. doi:10.1093/eurheartj/ehu4.